Advertisement

Life-Sciences-UK.com
The British Life Sciences Web Portal
This is a free web portal for the life sciences in the UK and Ireland... » read more
- Aldena Tx Emerges with $30m Investment from Medicxi (2023-03-16)
> Founded by Medicxi with Georgia Tech and UMass scientists, supported by US $30M investment from Medicxi > Developing advanced, long-lasting therapies for dermatological diseases through radical new transepidermal delivery of proprietary siRNAs > Led by derma... - Owlstone Medical Partners with Bicycle Therapeutics (2023-03-15)
> Research will focus on applying Bicycle’s bicyclic peptide technology to Owlstone’s EVOC probes > Antigen-targeted EVOC probes have potential for use in preclinical research, clinical trials, and as companion diagnostics and tests for early detection of disease... - CN Bio Appoints Deepak Singh as VP of Sales and Marketing (2023-03-14)
Key appointment as company seeks to continue global expansion of microphysiological systems and contract research service offerings CN Bio, a leading Organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems ... - Exscientia Regains Rights to Two Drug Candidates from BMS (2023-03-14)
— Precision designed LSD1 and MALT1 inhibitors currently progressing through IND-enabling studies — — Both m olecules demonstrate Exscientia’s ability to overcome critical design challenges and identify high quality drug candidates with potential increased proba... - Teitur Trophics Raises €28m Series A Financing (2023-03-14)
> Financing co-led by Sunstone Life Science Ventures and Sound Bioventures with participation from Industrifonden, Innovestor’s Life Science Fund and P53 Invest > Discovery of a novel mechanism with the potential to prevent the death of neurons in neurodegenerat... - Cancer Research UK & UCB to Develop Cancer Antibody Drugs (2023-03-09)
Cancer Research UK, the world’s largest charitable funder of cancer research, and UCB (EURONEXT BRUSSELS: UCB), a global biopharmaceutical company, today announced a clinical development collaboration to advance two of UCB’s investigational oncology antibody candid... - Exscientia & Charité to Advance Precision Medicine Platform (2023-03-07)
— Partnership will further validate Exscientia’s functional drug testing platform to predict response in haematological cancers — Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with Charité – Universitätsmedizin Berlin (Charité) to utilise E... - Oculis Lists at Nasdaq via SPAC Merger with $117m in Cash (2023-03-03)
> Closing of business combination with European Biotech Acquisition Corp. creates Nasdaq-listed ophthalmology company, under the ticker “OCS”, with advanced clinical-stage pipeline of multiple product candidates in key areas of medical needs such as retina, dry eye... - Antiverse: $3m Investment from New & Existing Investors (2023-03-01)
Seven human G-protein coupled receptor antibodies were characterised, showing high affinity and blocking function. $3 million USD investments will enable further development of these assets in-house. [picture] Structural model showing the 7 functional GPCR bin... - Five Alarm Bio Raises >£500k Seed Investment Round (2023-02-27)
> Investors include Cambridge Angels, Meltwind, o2h Ventures, SyndicateRoom, and Angel investors, with support from KPMG Acceleris > Funding will drive proprietary research into novel compounds that extend healthy lifespan of cells and tissues, with therapeutic ...
Life-Sciences-UK.com is your doorway to the British and Irish life sciences!
[LSUK] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the UK and Ireland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!
» Start here with the latest News!Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top